SCHEMBL7590154

SCHEMBL7590154

CC(O)CC#CCOCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
LMNA P02545 2/20 0.47
CA1 P00915 3/20 0.46
TSHR P16473 2/20 0.45
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
MMP2 P08253 2/20 0.42
MMP12 P39900 2/20 0.42
KMT2A Q03164 1/20 0.42
ALOX5 P09917 1/20 0.41
HTT P42858 2/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7587316 1.00 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2LMNACA1TSHR
SCHEMBL6508653 0.82 TSHR (0.67) ALDH1A1SMN1; SMN2LMNACA1TSHR
SCHEMBL12341355 0.81 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2LMNACA1TSHR
SCHEMBL16406073 0.81 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2LMNACA1TSHR
SCHEMBL8921592 0.79 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2LMNATSHRMMP2
SCHEMBL7589072 0.79 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2LMNATSHRMMP2
SCHEMBL15000482 0.77 TSHR (0.50) ALDH1A1SMN1; SMN2LMNACA1TSHR
SCHEMBL3268152 0.77 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2LMNACA1TSHR
SCHEMBL30381605 0.77 TRPA1 (0.40) LMNATSHRMMP2
Isopropyl Alcohol SCHEMBL29076646 0.76 TSHR (0.71) ALDH1A1LMNACA1TSHRCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0759915-B1 ASYMMETRIC SYNTHESIS OF CHIRAL SECONDARY ALCOHOLS CELL THERAPEUTICS INC (US) 2002-10-16 EP disclosed
US-6057328-A TREATING CONDITIONS RESULTING FROM HYPEROXIA, AND IN PARTICULAR, CONDITIONS RESULTING FROM THERAPEUTIC ADMINISTRATION OF OXYGEN COMPRISING ADMINISTERING XANTHINE COMPOUNDS CELL THERAPEUTICS, INC. (US) 2000-05-02 US disclosed
WO-1999033468-A9 METHOD FOR TREATING HYPEROXIA CELL THERAPEUTICS INC (US) 1999-09-23 WO disclosed
WO-1999033468-A1 METHOD FOR TREATING HYPEROXIA CELL THERAPEUTICS, INC. (US) 1999-07-08 WO disclosed
US-5629423-A Asymmetric synthesis of chiral secondary alcohols CELL THERAPEUTICS, INC. (US) 1997-05-13 US disclosed
EP-0759915-A1 ASYMMETRIC SYNTHESIS OF CHIRAL SECONDARY ALCOHOLS CELL THERAPEUTICS, INC. (US) 1997-03-05 EP disclosed
WO-1995031450-A1 ASYMMETRIC SYNTHESIS OF CHIRAL SECONDARY ALCOHOLS CELL THERAPEUTICS, INC. (US) 1995-11-23 WO disclosed